DE69617395T2 - Pharmazeutische zusammensetzungen enthaltent ein superoxyddismutase - Google Patents
Pharmazeutische zusammensetzungen enthaltent ein superoxyddismutaseInfo
- Publication number
- DE69617395T2 DE69617395T2 DE69617395T DE69617395T DE69617395T2 DE 69617395 T2 DE69617395 T2 DE 69617395T2 DE 69617395 T DE69617395 T DE 69617395T DE 69617395 T DE69617395 T DE 69617395T DE 69617395 T2 DE69617395 T2 DE 69617395T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- pharmaceutical compositions
- dismutase
- superoxyd
- compositions contain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract 3
- 108010012715 Superoxide dismutase Proteins 0.000 abstract 3
- 150000002632 lipids Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229940106189 ceramide Drugs 0.000 abstract 1
- 150000001783 ceramides Chemical class 0.000 abstract 1
- 229920006254 polymer film Polymers 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9500309A FR2729296B1 (fr) | 1995-01-12 | 1995-01-12 | Compositions pharmaceutiques comprenant une superoxyde dismutase |
PCT/FR1996/000055 WO1996021462A1 (fr) | 1995-01-12 | 1996-01-12 | Compositions pharmaceutiques comprenant une superoxyde dismutase |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69617395D1 DE69617395D1 (de) | 2002-01-10 |
DE69617395T2 true DE69617395T2 (de) | 2002-08-22 |
Family
ID=9475077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69617395T Expired - Fee Related DE69617395T2 (de) | 1995-01-12 | 1996-01-12 | Pharmazeutische zusammensetzungen enthaltent ein superoxyddismutase |
Country Status (8)
Country | Link |
---|---|
US (1) | US6045809A (de) |
EP (1) | EP0804225B1 (de) |
JP (1) | JP3856825B2 (de) |
AT (1) | ATE209504T1 (de) |
DE (1) | DE69617395T2 (de) |
ES (1) | ES2168457T3 (de) |
FR (1) | FR2729296B1 (de) |
WO (1) | WO1996021462A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2759288A1 (fr) * | 1997-02-12 | 1998-08-14 | Gredeco Groupe De Rech En Derm | Nouveau gel a base de gliadine |
EP1024788A1 (de) * | 1997-10-03 | 2000-08-09 | Lavipharm Laboratories, Inc. | Zusammensetzung enthaltend prolamin und pflanzlichen polarelipiden, verfahren zu ihrer herstellung und ihrer verwendung |
FR2770843B1 (fr) * | 1997-11-13 | 2000-01-14 | Lavipharm Lab | Association prolamines-lipides polaires vegetaux, son procede de preparation et ses applications |
DE69927154T2 (de) * | 1998-06-25 | 2006-06-29 | Lavipharm Laboratories, Inc. | Vorrichtung und verfahren zur behandlung von erektionsstörungen |
FR2820323B1 (fr) * | 2001-02-07 | 2004-10-08 | Innoform Sa | Composition dietetique et cosmetique a base de polymeres vegetaux immobilisant des actifs |
FR2822381B1 (fr) | 2001-03-20 | 2004-10-22 | Bio Obtention Sc | Extrait de cucumis melo enrobe et/ou microencapsule dans un agent liposoluble a base de matiere grasse |
US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
JP4599604B2 (ja) * | 2002-04-19 | 2010-12-15 | カーギル テクスチュアライジング ソリューションズ ドイチュラント ゲゼルシャフト ミット ベシュレクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト | 生体活性のリン脂質含有成分を含有するマトリックス |
JP2004099459A (ja) * | 2002-09-05 | 2004-04-02 | Asama Chemical Co Ltd | 抗腫瘍剤 |
JP2005336072A (ja) * | 2004-05-25 | 2005-12-08 | Combi Corp | 腎障害抑制剤 |
JP5275537B2 (ja) * | 2004-08-24 | 2013-08-28 | 学校法人日本医科大学 | 筋肉の酸化ストレス由来疾患予防経口剤 |
WO2006116452A1 (en) * | 2005-04-22 | 2006-11-02 | Molecular Regenix, Llc | Nutritional composition comprising hyaluronic acid and superoxide dismutase and methods of making and using same |
US20060257493A1 (en) * | 2005-04-28 | 2006-11-16 | Amiji Mansoor M | Nanoparticulate delivery systems for treating multi-drug resistance |
GB0603975D0 (en) * | 2006-03-01 | 2006-04-05 | Etren | Methods and agents for reducing oxidative stress |
US8092794B2 (en) * | 2006-03-15 | 2012-01-10 | Isocell Pharma S.A. | Pharmaceutical compositions comprising SODs and prolamine based peptide fragments |
US20080119386A1 (en) * | 2006-11-22 | 2008-05-22 | Carl Germano | Nutritional formula for athletes' recovery |
WO2009104649A1 (ja) * | 2008-02-22 | 2009-08-27 | 片山化学工業株式会社 | 合成糖脂質含有リポソーム |
PL2433640T3 (pl) * | 2010-09-24 | 2020-06-01 | Omnivision Gmbh | Kompozycja zawierająca SOD, luteinę i zeaksantynę |
SG11201506963UA (en) * | 2013-03-07 | 2015-10-29 | Barmarsa Res Llc | Kits and methods for the treatment of cancer using gliadin peptides |
FR3031040B1 (fr) | 2014-12-29 | 2018-09-07 | Universite De Bretagne Occidentale | Procede d'obtention d'un extrait proteique concentre en superoxydase dismutase (sod) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3853493T2 (de) * | 1987-05-28 | 1995-07-27 | Hiroshi Maeda | Superoxid-Dismutase-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel. |
JPH0262829A (ja) * | 1988-05-18 | 1990-03-02 | Nippon Kayaku Co Ltd | 虚血に基づく傷害の予防及び治療剤 |
US5019400A (en) * | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
US5271961A (en) * | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
JP2937446B2 (ja) * | 1990-09-14 | 1999-08-23 | 株式会社資生堂 | 白髪防止黒化剤 |
FR2711138B1 (fr) * | 1993-10-12 | 1995-11-24 | Oreal | Céramides, leur procédé de préparation et leurs applications en cosmétique et en dermopharmacie. |
-
1995
- 1995-01-12 FR FR9500309A patent/FR2729296B1/fr not_active Expired - Lifetime
-
1996
- 1996-01-12 JP JP52061696A patent/JP3856825B2/ja not_active Expired - Lifetime
- 1996-01-12 US US08/860,965 patent/US6045809A/en not_active Expired - Lifetime
- 1996-01-12 DE DE69617395T patent/DE69617395T2/de not_active Expired - Fee Related
- 1996-01-12 WO PCT/FR1996/000055 patent/WO1996021462A1/fr not_active Application Discontinuation
- 1996-01-12 ES ES96901386T patent/ES2168457T3/es not_active Expired - Lifetime
- 1996-01-12 AT AT96901386T patent/ATE209504T1/de not_active IP Right Cessation
- 1996-01-12 EP EP96901386A patent/EP0804225B1/de not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
FR2729296B1 (fr) | 1997-03-28 |
EP0804225A1 (de) | 1997-11-05 |
ATE209504T1 (de) | 2001-12-15 |
FR2729296A1 (fr) | 1996-07-19 |
EP0804225B1 (de) | 2001-11-28 |
DE69617395D1 (de) | 2002-01-10 |
JPH10511944A (ja) | 1998-11-17 |
WO1996021462A1 (fr) | 1996-07-18 |
ES2168457T3 (es) | 2002-06-16 |
US6045809A (en) | 2000-04-04 |
JP3856825B2 (ja) | 2006-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69617395T2 (de) | Pharmazeutische zusammensetzungen enthaltent ein superoxyddismutase | |
AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
DE69531741D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
DE69432076D1 (de) | Neue pharmazeutische formulierungen | |
TR199800902T2 (xx) | Ecza form�lasyonlar�. | |
ATE493998T1 (de) | Pharmazeutische zusammensetzung mit einem exendin-4-peptid | |
ATE131039T1 (de) | Arzneimittel in gelform in einem spender. | |
ATE306931T1 (de) | Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer | |
GEP20022851B (en) | Flash-Melt Oral Dosage Formulation | |
HUP0001917A2 (hu) | Sclerosis multiplex kezelése kopolimer-1 bevételével vagy inhalálásával | |
TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
CA2377174A1 (en) | Oral administration forms for administering a fixed tramadol and diclofenac combination | |
HK1030885A1 (en) | The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease | |
DE59811768D1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
TR200000291T2 (tr) | Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler. | |
CA2217513A1 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
NO963634D0 (no) | Antihostepreparat inneholdende et antihostemiddel og benzydamin | |
WO1999013916A3 (en) | Methods and compositions for medical imaging | |
ATE198481T1 (de) | Bizyclische tachykinin-antagonisten, deren herstellung und deren verwendung in pharmazeutischen zusammmensetzungen | |
CA2273272A1 (en) | Immediate release drug delivery forms | |
CY1105624T1 (el) | Αντιγλαυκωματικο μεσο και χρηση αυτου | |
DK0927031T3 (da) | Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration | |
WO1998036778A8 (en) | Sustained drug delivery and compositions useful therefor | |
AU7533394A (en) | Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel | |
BR9506507A (pt) | Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8339 | Ceased/non-payment of the annual fee |